Home » Newsletters » BioWorld

BioWorld

Jan. 9, 1992

View Archived Issues

GENPHARM RAISES $12 MILLION

COLLAGEN LAWSUIT DROPPED

MOLECULAR BIO IMAGING AGENT ENTERS PHASE I

IMRE ARTHRITIS TREATMENT TRIALS APPROVED

GLYCOMED RECEIVES PATENT NOTICE

NOVA GETS PATENT FOR LEUMEDIN COMPOUNDS

SPAIN APPROVES CYTOGEN'S ONCOSCINT

MGI CONVERTS PREFERRED STOCK

BIOMIRA STOCK CONTINUES TO RISE

CALGENE TO GET ANTISENSE PATENT

IMMUNOMEDICS TO GET BROAD PATENT

GENSIA, SANDOZ TO PURSUE DIABETES DRUGS

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...